Cardiovascular Systems, Inc

Short Term Long Term Short Term Comparison Long Term Comparison

CSII
1d0.00%
1w0.00%
1m0.00%
1y0.00%
CSII
1y0.00%
5y0.00%
10y0.00%
20y0.00%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$104.00
ATH Date2006-08-08
% since ATH-100.00%
% to ATHinf%

ATL

ATL Price$3.50
ATL Date2008-11-18
% from ATL-100.00%
Last Low Price$3.5
Last Low Date2008-11-18
% From Last Low-100.00%

IPO

IPO Price$10.00
% Current ROI USD-100.00%
ATH Price$104.00
% ROI ATH 297,142.86%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="CSII"]

Key Data [addtoany]

Current price	$
Sector	Healthcare
Industry	Medical Devices
Today's High/Low	$/$
Volume	0.00
Previous Close	$
52 Week High/Low	$20/$19.7
Market Cap	843,960,000.00
P/E Ratio	0
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$-0.47
Annualized Dividend	$0

[addtoany]

Cardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States.
The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions.
The company has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Annual Data \| Millions of US $ except per share data	2019-06-30	2018-06-30	2017-06-30	2016-06-30	2015-06-30	2014-06-30	2013-06-30	2012-06-30	2011-06-30	2010-06-30	2009-06-30	2008-06-30	2007-06-30
Cash on hand	$122.67	$116.80	$108.62	$61.32	$85.72	-	-	-	-	-	-	-	-
Receivables	$36.02	$31.23	$28.47	$23.13	$30.83	$21.38	-	-	-	-	-	-	-
Inventory	$18.06	$16.61	$16.90	$17.44	$13.97	$12.89	$6.24	$7.06	$5.82	$4.32	$3.37	$3.78	$1.05
Pre-Paid Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	$3.33	$2.98	$5.07	$2.99	$3.38	$1.85	$0.96	$1.54	$0.80	$1.05	$0.80	$1.94	$0.26
Total Current Assets	$180.08	$167.61	$159.06	$104.88	$133.89	$0	$0	$0	-	-	-	-	-
Property, Plant, And Equipment	$27.32	$27.74	$29.70	$32.47	$32.88	$15.30	$3	$2.16	$2.38	$1.96	$1.72	$1.04	$0.59
Long-Term Investments	$5.59	$2.54	-	-	-	-	-	-	-	-	-	-	-
Goodwill And Intangible Assets	-	$0	$0	$0	$0	$0	$0	$0	-	-	-	-	-
Other Long-Term Assets	$0.48	$0.23	$0.13	$0.04	$0.04	$0.07	$0.85	$0.56	$1.03	$0.18	$0.44	-	-
Total Long-Term Assets	$38.50	$35.74	$34.88	$37.52	-	-	-	-	-	-	-	-	-
Total Assets	$218.58	$203.35	$193.94	$142.41	$171.33	$181.90	$96.90	$63.12	$46.76	$42.33	$72.37	$41.96	$22.03
Total Current Liabilities	$42.35	$37.46	$40.97	$35.50	$29.89	$29.73	$22.41	$17.85	$15.19	$14.72	$36.17	$21.32	$2.66
Long Term Debt	-	$21.06	$21.10	$0	$0	$0	$7.47	$12.84	$8.33	$7.29	$4.38	$3.99	$3.09
Other Non-Current Liabilities	$7.32	$10.36	$13.48	$6.01	$2.01	$0.12	$0.18	$0.24	$1.61	$2.62	$1.49	$0.10	$0.08
Total Long Term Liabilities	$28.29	$31.42	$34.58	$6.01	-	-	-	-	-	-	-	-	-
Total Liabilities	$70.63	$68.88	$75.55	$41.51	$31.89	$29.85	$30.07	$30.94	$25.12	$24.62	$42.04	$25.41	$5.83
Common Stock Net	$0.03	$0.03	$0.03	$0.03	$0.03	$0.03	$0.02	$0.02	$0.02	$0.02	$0.01	$35.93	$26.05
Retained Earnings (Accumulated Deficit)	$-329.54	$-327.59	$-329.30	$-327.41	$-271.39	$0	$0	$0	-	-	-	-	-
Comprehensive Income	-	$0	$0	$0	$0	$0	$0	$0	-	-	-	-	-
Other Share Holders Equity	$0.08	$0.10	$0.10	$0.04	$0.09	$0.09	-	-	-	-	-	-	-
Share Holder Equity	$147.94	$134.47	$118.39	$100.90	$139.44	$152.06	$66.83	$32.19	$21.64	$17.72	$30.33	$16.55	$16.20
Total Liabilities And Share Holders Equity	$218.58	$203.35	$193.94	$142.41	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-06-30	2018-06-30	2017-06-30	2016-06-30	2015-06-30	2014-06-30	2013-06-30	2012-06-30	2011-06-30	2010-06-30	2009-06-30	2008-06-30	2007-06-30
Revenue	$248.02	$217.04	$204.91	$178.18	$178.81	$136.61	$103.90	$82.49	$78.78	$64.83	$56.46	$22.18	-
Cost Of Goods Sold	$47.68	$39.48	$39.44	$35.42	$36.79	$31.95	$24.40	$18.34	$15.56	$14.40	$15.72	$8.63	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Expenses	$33.46	$26.76	$22.91	$25.93	$30.98	$21.07	$15.22	$11.37	$8.94	$10.28	$14.68	$16.07	$8.45
SG&A Expenses	$167.70	$148.57	$144.10	$162.54	$143.68	$117.99	$86.72	$66.37	$71.06	$72.73	$72.80	$51.39	$14.94
Other Operating Income Or Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	$248.84	$214.81	$206.45	$223.90	$174.66	$139.06	$101.93	$77.74	-	-	-	-	-
Operating Income	$-0.83	$2.23	$-1.54	$-45.71	$-32.64	$-33.49	$-22.42	$-14.47	-	-	-	-	-
Total Non-Operating Income/Expense	$2.44	-	-	$0.05	$-0.19	$-1.80	$-1.62	$-2.32	-	-	-	-	-
Pre-Tax Income	$-0.07	$1.84	$-1.71	$-56.02	$-32.71	$-35.29	$-24.04	$-16.79	-	-	-	-	-
Income Taxes	$0.19	$0.13	$0.09	$0.09	$0.11	$0	$0	$0	-	-	-	-	-
Income After Taxes	$0.19	$0.13	$0.09	$0.09	$0.11	$0	$0	$0	-	-	-	-	-
Other Income	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Continuous Operations	$-0.26	$1.71	$-1.79	$-56.02	$-32.82	$-35.29	$-24.04	$-16.79	-	-	-	-	-
Income From Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	$-0.26	$1.71	$-1.79	$-56.02	$-32.82	$-35.29	$-24.04	$-16.79	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	$-0.83	$2.23	$-1.54	$-45.71	$-32.64	$-33.49	$-22.42	$-14.47	-	-	-	-	-
Basic Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	$34	$34	$32	$33	$32	$28	$22	$18	$16	$15	$8	$3	$3
Basic EPS	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-06-30	2018-06-30	2017-06-30	2016-06-30	2015-06-30	2014-06-30	2013-06-30	2012-06-30	2011-06-30	2010-06-30	2009-06-30	2008-06-30	2007-06-30
Net Income/Loss	$-0.26	$1.71	$-1.79	$-56.02	$-32.82	$-35.29	$-24.04	$-16.79	-	-	-	-	-
Total Depreciation And Amortization - Cash Flow	$3.45	$3.93	$4.14	$3.92	$0.17	$0.26	$0.01	$-0.01	-	-	-	-	-
Change In Accounts Receivable	$-4.92	$-2.88	$-5.81	$7.33	$-10.57	$6.72	$1.28	$0	-	-	-	-	-
Change In Inventories	$-1.45	$0.29	$0.54	$-3.47	$-1.08	$-6.65	$0.82	$-1.24	-	-	$0.41	-	-
Cash Flow From Operating Activities	$10.21	$9.67	$19.59	$-23.58	$-22.36	$-26.84	$-10.77	$-11.34	-	-	-	-	-
Cash Flow From Investing Activities	$-54.35	$-5.10	$-1.78	$-3.77	$-23.03	$-13.42	$-2.46	$-0.98	-	$21.76	$36.03	-	-
Debt Issuance/Retirement Net - Total	-	-	$20.94	$20.94	$-2.40	$-5.05	$-0.30	$5.95	-	-	-	-	-
Total Common And Preferred Stock Dividends Paid	-	$0	$0	$0	$0	$0	$0	$0	-	-	-	-	-
Financial Activities - Other	$-0.04	$0.01	$0400000	$0400000	$2.15	$16.26	$5.93	$4.43	-	-	$0.08	-	-
Cash Flow From Financial Activities	$2.12	$3.77	$29.47	$4.15	$2.63	$98.95	$45.59	$26.69	$7.54	-	$19.50	$44	$30.48
Net Cash Flow	$-42.02	$8.35	$47.27	$-23.20	$-42.75	$58.70	$32.37	$14.37	-	-	-	-	-
Common Stock Dividends Paid	-	$0	$0	$0	$0	$0	$0	$0	-	-	-	-	-